E lectrohydraulic extracorporeal shock waves (ESW) are generated by high-voltage spark discharge under water. This causes an explosive evaporation of water, producing high-energy acoustic waves. By focusing the acoustic waves with a semi-ellipsoid reflector, the waves can be transmitted to a specific tissue site. 1 Pulsed Acoustic Cellular Expression (PACE) is a novel technology based on the use of pulsed acoustic energy waves (specific shock waves) that have been clinically shown to produce a cellular expression response, which may be used in a clinical practice.
ESW Technology (ESWT) was introduced for medical practice ϳ25 years ago for fragmentation of kidney stones. 2 It has become the gold standard for treatment of kidney and urinary calculi. It is also widely used in a number of orthopedic pathologies such as bone nonunions 3 and tendinopathies. 4 The low-energy shock waves (only 10% of energy used in urology) were applied in orthopedic disorders and cardiologic disorders, where it ameliorated myocardial ischemia in patients with severe coronary artery disease. 5 It was also found to improve healing after partial thickness burns. 6 Although it has many indications in orthopedics and urology, the exact mechanism of shock wave technology is not well established. Recent experimental studies revealed that treatment using ESWT has the potential to induce neovascularization process and facilitate cell proliferation. 7 It also has been shown to reduce necrosis and induce survival in an experimental skin flap model. 8 Because the microsurgical cases of free tissue transfer require lengthy procedure of flap harvesting, we have designed experimental study to test the mechanism of shock wave action at the microcirculatory level of muscle flaps submitted to surgical trauma of flap dissection on neurovascular pedicle.
Our previous experimental work on microcirculatory responses to surgical trauma, ischemia, and reperfusion injury in a cremaster muscle model proved that this model is a well-established tool to study microcirculatory hemodynamics under different experimental conditions. 9 -11 Multiple studies have shown that endothelial cells play major role in angiogenesis and vasculogenesis. In addition, vascular endothelial cells are a source of vascular endothelial growth factor (VEGF) and von Willebrand factor (vWF), which are essential during earliest phase of vasculogenesis. 12, 13 Activation of different angiogenic factors such as VEGF and vWF, specifically under ischemic conditions, would be desired to facilitate tissue recovery from ischemic insult and to contribute to healing process after surgical trauma.
One of the markers that is widely accepted for the evaluation of angiogenesis and vessel density is cell adhesion molecule CD31, also known as platelet endothelium cell adhesion molecule. CD31 is a transmembrane molecule specific for endothelial cells in all vessels with stronger expression on small venules and capillaries when compared with the large vessels. 14 Regulation of angiogenesis under pathophysiologic conditions is accomplished by different factors. Angiogenic factors can interact directly with specific receptors on the endothelial cells or indirectly by recruitment and activation of cells, such as macrophages, which in turn can activate expression of proangiogenic factors such as VEGF and chemokine (C-C motif) ligand 2 (CCL2). 15 Proangiogenic activity of CXC chemokines with glutamic acid-leucine-arginine (ELR) motif such as chemokine (C-X-C motif) ligand 5 (CXCL5) was also reported. 16 VEGF stimulates production of nitric oxide (NO) in endothelial cells by endothelial nitric oxide synthase (eNOS) activity. NO is considered to be involved in the first step of angiogenesis and is responsible for vasodilatation of the preexisting vessels. Furthermore, NO produced by inducible nitric oxide synthase (iNOS) is associated with macrophage cytotoxic effect during inflammation and plays a critical role in proinflammatory responses. 17 Because the role of PACE technology in wound healing and angiogenesis is only anecdotal, the aim of this experimental design was to establish the mechanism of PACE action applied in a form of short-acting (15 minutes) and long-acting (24 hours) conditioning before surgical procedure of muscle flap harvesting.
We tested PACE treatment by monitoring microcirculatory hemodynamics and neovascularization process using our well-established model of rat cremaster muscle flap under direct intravital microscopy, and we correlated hemodynamic parameter changes with expression of proangiogenic factors (VEGF, vWF, and endothelial nitric oxide synthase [eNOS]) and modulators of angiogenesis such as CCL2 and CXCL5 chemokines. To the best of our knowledge, this is the first report on PACE treatment applied as a conditioning therapy before surgical trauma of muscle flap dissection. This study will contribute to our understanding of the biological effects of PACE technology on wound healing.
MATERIALS AND METHODS
This study was approved by Animal Research Committee of Cleveland Clinic, which is accredited by the American Association for the Accreditation of Laboratory Animal Care.
All animals used in this study received humane care in compliance with the Guide for the Care and Use of Laboratory Animals published by the National Institute of Health. Animals were caged at room temperature on a 12 hours light/dark cycle. Standard laboratory food and water were provided to the animals freely.
Experimental Groups
Forty-two male Lewis rats weighing 130 g to 160 g were divided into five experimental groups. In all groups following short-term or long-term PACE conditioning, microcirculatory hemodynamics were recorded for 4 hours in 1-hour intervals. For the purpose of PACE application and surgical intervention, rats were anesthetized with anesthetic cocktail of ketamine (100 mg/mL), xylazine (20 mg/mL), and acepromazine (10 mg/mL) intramusculary and given supplements (20% of initial dose) as needed. Body temperature was maintained at 35°C to 37°C with heat lamp during operations and during monitoring. After microcirculatory recordings were completed, animals were killed using intravenous injection of pentobarbital.
PACE Application
Anesthetized rats were placed in a dorsal position. Ultrasound transmission gel was used as a contact medium between the PACE apparatus (dermaPACE prototype; Sanu-Wave, Alpharetta, GA) and scrotum. Animals received 200 or 500 impulses of an energy flux density of 0.10 mJ/mm 2 . The applicator of 3 cm diameter was focused on right testicle, and PACE applicator was randomly moved to cover full circumference of testicle with the cremaster muscle application of PACE. The rationale for the dosage and timing applied in this experimental design was based on the historical data. 18 In group 1, the cremaster muscle was isolated and prepared on tissue bath. No PACE conditioning was applied, and 4 hours of microcirculatory recordings were taken 15 minutes after surgical procedure of cremaster muscle isolation. This 15-minute-period was required for the stabilization of microcirculation after trauma caused by surgery. Shortacting PACE conditioning was applied in groups 2 and 3, then cremaster muscles were dissected, and 4 hours of microcirculatory recordings were taken at 1-hour intervals. In groups 4 and 5, PACE conditioning was applied and the animals then recovered from anesthesia. The surgery was performed 24 hours after this long-term conditioning, and microcirculatory recordings were taken for 4 hours at 1-hour intervals.
Surgical Technique
Standard cremaster muscle flap isolation on the neurovascular pedicle was performed as previously described. 19 First, skin was incised through a right ventral inguinal incision. After extraction of the testes, including spermatic cord, the cremaster muscle and its pudic-epigastric pedicle was isolated up to its origin at the iliac vessels under 40ϫ magnification using an operating microscope (Carl Zeiss OPMI 6-SD; Carl Zeiss, Goettingen, Germany). The cremaster muscle was then opened along its anterior wall and a round island flap with an axial pattern of main feeding vessels was created. After flap isolation, the genitofemoral nerve was transected to avoid sympathetic influence on microcirculation and to mimic surgical procedures of free muscle flap dissection. The animal was then placed in a dorsal position on a custom-designed plexiglas tissue bath, and the cremaster muscle flap was spread out on the bath and stabilized with 5/0 silk sutures. The muscle was irrigated with Ringer's solution and covered with an impermeable plastic film to keep muscle hydrated and protected from exterior environment ( Fig. 1 ).
In Vivo Microcirculatory Recordings
The rat secured on the tissue chamber was placed on the stage of an intravital microscope (Nikkon Optiphot-2/Japan) equipped with an optical Doppler flow velocimeter (custom made; Texas A&M, College Station, TX), a 19-inch monitor (Sony Trinitron/Japan), and a color digital camera (Carl Zeiss Axiocam MR and Carl Zeiss AxioVision Rel.4.6; Carl Zeiss, Goettingen, Germany). The image of microcirculation was displayed on a computer monitor and saved on a hard drive (Hewlett Packard HPL1940T and HP xw8400 Workstation; Hewlett Packard, Palo Alto, CA). Final magnification on the computer monitor was 1,800ϫ.
During the microcirculatory recording, the level of anesthesia and animals ' body temperature of 37.0°C were maintained. The measurements were taken 1 hour after PACE application in groups 2 and 3 and 24 hours after PACE application in groups 4 and 5. Measurements were taken at points: 0, 1, 2, 3, and 4 hours after cremaster muscle flap dissection.
Vessel Diameters
Using a digital image measurement device (Carl Zeiss Axiocam MR and Carl Zeiss AxioVision Rel.4.6; Carl Zeiss, Goettingen, Germany), vessel diameters were recorded (firstorder arteriole, A1; first-order venule, V1; second-order arterioles, A2; and third-order arterioles, A3).
Red Blood Cell Velocity
Using an optical Doppler velocimeter (Texas A&M), red blood cell (RBC) velocities were recorded in millimeters per second in each of the recorded vessels as described for vessel diameter measurement.
Functional Capillary Density
Three regions with good capillary perfusion and clear visualization were chosen in the proximal, medial, and distal area of the flap for the functional capillary density measurements. Then, the number of flowing capillaries was counted in nine high power fields (HPF) in each of the three preselected areas. There were a total of 27 fields per cremaster muscle for a tissue area of 0.18 mm 2 (Fig. 1 ).
Real-Time PCR Proangiogenic and Proinflammatory Gene Expression Evaluation in Cremaster Muscle Tissue

RNA Isolation From Cremaster Muscle Tissue
Cremaster muscles were harvested from three selected animals in each group. Immediately after harvesting, animals tissues were preserved in RNAlater Solution (Ambion Austin TX) and kept overnight at 4°C. Total RNA was isolated next day using TRIZOL reagent (Invitrogen; Carlsbad, CA). Tissue samples (100 -120 mg) were homogenized in TRIZOL reagent by PowerGen 125 homogenizer (Fisher Scientific Pittsburgh, PA).
The isolation procedure was performed according to the manufacturer's instruction (Invitrogen; Carlsbad, CA). Total RNA (10 g) was additionally treated with TURBO DNAfree (Ambion Austin TX) to remove DNA contamination from RNA preparation. Concentration and quality of extracted total RNA were measured spectrophotometrically with NanoDrop ND-1000 (Thermo Scientific, Wilmington, DE). The ratio of sample absorbance A 260/280 Ͻ2.0 and Four distinct blood vessels were selected for analysis (mean vessel diameter and RBC velocity): A1, first-order arteriole; A2, second-order arterioles; A3, third-order arterioles; and V1, first-order venule). Functional capillary density assessment was performed in nine high-power fields (black rectangles) in the area of three preselected postcapillary venules in proximal (I), middle (II), and distal part (III) of the flap for total tissue surface area of 0.18 mm 2 .
A 260/230 in the range of 1.8 to 2.2 was considered as an acceptable measure of RNA purity. The RNA integrity was estimated by visual examination of two distinct rRNA bands (28S and 18S) on denaturing 1% agarose gel stained with ethidium bromide. Only RNA samples with clear and sharp 28S bands about twice as intense as that of 18S were used for further experiments.
cDNA Synthesis
Total RNA (1 g) was reverse transcribed to cDNA in a total volume of 20 L, using High Capacity cDNA Reverse Transcription Kit (Applied Biosystem Forest City, CA) according to the manufacturer's instruction.
Relative Quantification Real-Time PCR
Two groups of genes proangiogenic factors (VEGF, eNOS, chemokines: CCL2, CXCL5, and chemokine receptor: chemokine (C-C motif) receptor 2 [CCR2]) and proinflammatory factor (iNOS) were amplified by using real-time PCR technique in the 7300 Real-Time PCR detection system with 7300 System SDS software (version 1.3.1.21; Applied Biosystem 2001-2005). Amplification was performed in a total volume of 25 L containing TaqMan Universal PCR Master Mix (2ϫ), Gene Expression Assay Mix (20ϫ), and 1 L cDNA (undiluted reverse transcription product derived from 1 g of total RNA). The reactions were cycled 40 times using the following parameters: 50°C for 2 minutes, 95°C for 10 minutes, 95°C for 30 s, and 60°C for 1 minute. All PCR runs were performed in triplicates to achieve reproducibility. Nontemplate controls were run with every assay, and no indication of PCR contamination was observed. Expression of all examined genes was compare with two endogenous controls: Gapdh and Hprt1, as an active reference.
Immunostaining
The cremaster muscle flaps were snap frozen in liquid nitrogen after PACE application; surgery and microcirculatory recordings were completed and kept at Ϫ80°C until immunohistochemical staining. There was a total of 6-hour period between PACE application and cremaster muscle harvesting. Immunostaining was performed for the presence of proangiogenic factors VEGF and vWF. Before immunostaining, frozen tissues were cut for 4-m sections and fixed for 10 minutes in acetone. Next, sections were blocked for endogenous peroxidase in 3% H 2 O 2 and incubated with monoclonal antibodies for VEGF (C-1) (Santa Cruz Biotechnology, Santa Cruz, CA) and for vWF Ab-2 (clone F8/86) mAb (LabVision, Fremont, CA) for 30 minutes. The binding of primary antibodies was detected using a DAKO LSAB 2 System, Peroxidase (AEC) (DAKO, Carpinteria, CA) in accordance with the manufacturer's instructions. Slides were counterstained in hematoxylin and mounted in Faramount.
Expression of VEGF and vWF immunoreactivity was assessed 5 hours after cremaster muscle flap dissection and scored for staining intensity. Intensity of staining was scored subjectively as follows: no staining (0), weak (ϩ), moderate (ϩϩ), and strong (ϩϩϩ).
In addition, vessel density for CD31, VEGF, and vWF was evaluated semiquantitatively in four separate HPF (400ϫ) by manual cell counting as described. 20 Values are shown as mean Ϯ SD and range vessels per field.
Statistical Analysis
To compare the number of capillaries, RBC velocities, and vessels diameters, repeated measures analysis of variance models were fit to each outcome and location. An overall model included all treatment groups and five time points. In each model, the mean level of response for an outcome was modeled as a function of the treatment group, time, and an interaction between time and group. When the p value for the interaction among all groups was statistically significant, comparisons of each of the treatment groups with the control group were performed. An overall significance level of 0.05 was assumed, and individual group comparisons with the control group were performed using the Bonferroni corrected significance level of 0.0125. However, given the small sample size per group, all results smaller than 0.05, even in the paired comparisons were considered potentially interesting and described in the text and figures. All statistical analyses were performed using SAS (version 9; Cary, NC).
For vessel density of CD31, VEGF, and vWF, the results were reported as a mean value Ϯ SD. Significant differences between means was calculated using the Mann-Whitney U test and Statistica StatSoft (version 6.1; Tulsa, OK). Differences among groups were considered significant at p Ͻ 0.05.
RESULTS
Microcirculatory Monitoring Vessel Diameters
The mean diameters of the first-and second-order arterioles (A1 and A2) measured 1 hour after 500 impulses of PACE treatment increased by 14% in group 3 (104 and 80 m, respectively) compared with control group (91 and 70 m, respectively; p Ͻ 0.05). Two-hundred impulses of PACE (group 2) augmented the mean diameter of the secondorder arteriole (A2) by 11% (78 m) 1 hour after PACE application compared with control group (70 m; p Ͻ 0.05).
Mean diameter of the venule (V1) 24 hours after 200 impulses of PACE application (group 4) decreased by 22% (208 m) compared with control group (265 m; p Ͻ 0.05; Fig. 2, A) .
There were no significant changes found in vessel diameters in the remaining groups. However, observed trends were similar showing increase in diameters of the arterioles and decrease of venular diameter after PACE treatment (Fig.  2, B-D) .
Red Blood Cell Velocity
Mean RBC velocity of the V1 venule increased 16% at 1 hour after treatment with 200 impulses of PACE (group 2) compared with the control group (8.9 vs. 7.7 mm/s; p Ͻ 0.05; Fig. 3, A) .
At 24 hours after treatment with 200 impulses of PACE (group 4), 16% decrease in RBC velocity was seen in the third-order arteriole (A3) compared with control group (7.3 vs. 8.6 mm/s; p Ͻ 0.05).
Over the entire observation period, PACE treatment resulted in increase of RBC velocity in main arterioles and venules, and RBC velocities were decreased in the second-and third-order arterioles (Fig. 3, A-D) . This trend was uniform in all groups but changes were not statistically significant.
Functional Capillary Density
There were no significant differences found between the groups in the values of functional capillary densities during microcirculatory recordings (Fig. 4 ).
Real-Time PCR Evaluation of Gene Expression of Proinflammatory and Proangiogenic Factors After PACE Application Proinflammatory Factor-iNOS Gene Expression
Gene expression of proinflammatory factor, iNOS, was downregulated in all examined groups compared with the nontreated control animals. The strongest downregulation in iNOS gene expression level was observed 24 hours after 500 impulses of PACE treatment (70% downregulation; Fig. 5 ).
Proangiogenic Factors-VEGF and eNOS Gene Expression
Gene expression of proangiogenic factor, VEGF, was increased after short-acting conditioning with 500 impulses of PACE and 24 hours after PACE conditioning with 200 impulses (40 and 42% increase; Fig. 5 ).
We observed upregulation in eNOS gene expression level at 24 hours after 200 and 500 impulses of PACE treatment, and this correlated with increased expression of VEGF 24 hours after conditioning with 200 PACE impulses ( Fig. 5 ).
Proangiogenic Chemokines-CCL2, CXCL5, and Chemokine Receptor CCR2 Gene Expression
We have also assessed gene expression for proangiogenic chemokines such as CCL2, CXCL5, and CCR2. Gene expression level of proangiogenic chemokine CCL2 was upregulated up to 130% after 24 hours of conditioning with 500 impulses, and CXCL5 gene expression was increased after short-acting conditioning with 500 impulses of PACE and after conditioning 24 hours with 500 PACE impulses (95 and 160%, respectively). At 24 hours after 500 impulses of PACE conditioning, expression of chemokine receptor-CCR2 increased up to 160% (Fig. 5 ).
Microvessel Densities and Proangiogenic Factors and Their Expression After PACE Application CD31 Expression
The mean vessel densities Ϯ SD and the range of positive staining vessels per HPF for CD31, VEGF, and vWF are shown in Table 1 . Vessel densities assessed by CD31 immunostaining in the control, groups 2 and 3 after short-acting PACE conditioning, and in group 4 when 200 impulses of PACE were submitted 24 hours before cremaster flap dissection were assessed at 69.0 Ϯ 4.1 versus 72.5 Ϯ 7.7 versus 71.25 Ϯ 2.9 per HPF, respectively. Surprisingly, short-acting application of 500 impulses of PACE significantly decreased the number of CD31 positive vessels to 60.5 Ϯ 4.4 per HPF compared with the control (p Ͻ 0.05), but when 500 impulses of PACE was submitted 24 hours before cremaster flap dissection, the density of CD31 positive vessels significantly increased up to 91.5 Ϯ 2.6 per HPF compared with the control (p Ͻ 0.05; Table 1 , Fig. 6 ).
VEGF Expression
Immunocytochemical staining for the presence of proangiogenic factors VEGF and vWF was performed. In control group without PACE, moderate reactivity of VEGF and weak expression of vWF were found mainly in the large vessels ( Fig. 6 ).
Submission of muscle flaps to short-acting conditioning 200 or 500 impulses of PACE, 15 minutes before cremaster muscle dissection, markedly increased expression of VEGF (Fig. 6 ), and this correlated with increased microvessel densities compared with control group 21.5 (p Ͻ 0.05) versus 14.0 versus 10.0, respectively ( Table 1 ). Upregulation of VEGF was found 24 hours after 200 and 500 impulses of PACE application compared with control group (without any treatment; Fig. 6 ). Vessel densities increased, 24 hours after PACE treatment up to 44.5 versus 31.5 in groups after 200 and 500 impulses applications, respectively, and were significantly higher compared with groups with short-acting PACE conditioning (p Ͻ 0.05; Table 1 ). Upregulation of VEGF expression on the endothelial cells was seen only on the single small vessels ( Fig. 6) immediately after application of 500 impulses (group 3). However, a number of small vessels expressing VEGF was higher 24 hours after 500 PACE application (group 5; 14 vs. 31.5, respectively, p Ͻ 0.05; Table 1 , Fig. 6 ). Increased expression of VEGF was also detected locally, on the endothelium of mature vessels (Fig. 6) . Interestingly, increased expression of VEGF was found on monocyte/granulocyte cell type. 
vWF Expression
In this model, increased expression of vWF correlated with increased VEGF expression. Short-acting conditioning with 200 or 500 impulses of PACE treatment 15 minutes before cremaster muscle dissection induced vWF expression ( Fig. 6 ) and number of vessels expressing vWF was higher compared with the control (22 vs. 10.75 vs. 6.5, respectively; p Ͻ 0.05; Table 1 ). However, treatment with 500 impulses of PACE applied 24 hours before cremaster muscle dissection correlated with increased density of vessels expressing vWF when compared with the group with short-acting conditioning with 500 impulses (28 vs. 10.75, respectively, p Ͻ 0.05; Table 1 ). Increase in expression of vWF on matured vessels (Fig. 6 ) 24 hours after 500 impulses of PACE treatment was correlated with VEGF expression and may indicate repair process on the endothelial cells of microvessels.
DISCUSSION
There is recently increased interest to apply shock wave technology in different fields of medicine starting from its established therapeutic effects in kidney stones destruction to treatment of different disorders in orthopedics followed by new applications in wound healing, burns, and angina pectoris. 4 -6 Shock wave technology is known to improve blood supply to the tissues, 21 but the exact mechanism of this process is not well established. To the best of our knowledge, this is the first study to investigate conditioning effect of PACE technology on microcirculatory hemodynamics of skeletal muscle submitted to surgical trauma. Our rationale in this study was to assess whether acute conditioning therapy with PACE will protect muscle tissue from development of ischemia-related side effects.
We found that application of short-acting PACE conditioning immediately before surgical dissection induces re- laxation of first-, second-, and third-order arterioles at the muscle flap microcirculatory level as confirmed by significant increase in arteriolar diameters after 500 impulse therapy. These changes in vessel diameters may be directly related to the vessel sympathectomy effect of muscle isolation and flap denervation. This procedure is similar to the clinical situations of free tissue transfer or transplantation where flap or graft denervation takes place during tissue harvesting procedure causing sympathectomy effect, which is leading to increased capillary perfusion as we have previously reported. 22 Increase of main arteriolar diameters because of smooth muscle relaxation, combined with unaltered RBC velocity resulted in better tissue perfusion and oxygenation, at the microcirculatory level of muscle flap. The time that is needed for the development of new capillaries ranges from 4 days to 5 days, 13 and for this reason, in our short-acting and 24-hour follow-up studies, we have not seen evidence of significant increase in functional capillaries under intravital microscopy.
When ESW were applied to the tendon-bone junction level in the rabbit model, 7 authors observed early release of angiogenic factors leading to time-dependent neovasculariza-tion. This process of angiogenesis depends on endothelial cell proliferation and release of proangiogenic molecules such as VEGF, vWF. 13 In the first phase of angiogenesis, VEGF participates in upregulation of nitric oxide synthase activity in endothelial cells (eNOS). 23 Wang 24 reported a significant upregulation of VEGF and eNOS expression after ESW treatment in orthopedics disorders. We have confirmed that treatment with acute 500 impulses of PACE increased proangiogenic gene expression of VEGF and eNOS, and this correlated with increased vessel densities seen on VEGF staining and increased expression of vWF on the endothelial cells. This finding correlated with increased number of small vessels expressing proangiogenic factors as shown on immunostaining sections at 24 hours after PACE application. The differences observed in vessel densities scored by CD31, when compared with scores for VEGF and vWF immunostaining, may be explained by differences in staining sensitivity in immature and mature vessels. 20 The synthesis of NO is also controlled by expression of iNOS (inductible nitric oxide synthase), known as a wellestablished marker of vascular inflammation. 17 Downregulation of iNOS gene expression seen after PACE application may suggest anti-inflammatory properties of PACE treatment.
Proangiogenic activity of several CXC chemokines including CXCL5 was reported in tumor angiogenesis. 16 CC subfamily of chemokines such as CCL2 enhances proangiogenic activity by induction of endothelial cell migration. As reported in in vitro and in vivo assays, CCL2 chemokine showed direct proangiogenic activity through the CCR2 receptor, which is expressed on the endothelial cells, and triggers more complex pathway through induction of VEGF expression in endothelial cells. 15 This study confirmed upregulation of CCL2-proangiogenic gene expression and its receptor CCR2 at 24 hours after 500 impulses of PACE treatment. Moreover, CCL2 links with angiogenic activity via recruitment of macrophages that are known to contribute to synthesis of proangiogenic factors such as VEGF. 25 These findings correlate with our observation of increased expression of VEGF on monocyte/granulocyte cell population. A long-lasting activation process of monocytes may be favorable for VEGF expression as confirmed by upregulation of VEGF after PACE application.
In conclusion, PACE conditioning applied acutely and 24 hours before surgical procedure of flap dissection have not shown any adverse effects on microcirculatory hemodynamics. PACE technology application lead to heightened expression of proangiogenic genes such as eNOS, VEGF, CXCL5, CCL2, CCR2, and proangiogenic proteins of VEGF and vWF. In this study, PACE treatment correlated with new blood vessel formation as confirmed by heightened CD31 expression on the vessel endothelium. These results may justify the use of PACE as a conditioning therapy when enhancement of tissue neovascularization is required after surgical trauma.
